Josh Mandel-Brehm

CEO at Camp4 Therapeutics

Speaker

Josh Mandel-Brehm is President & Chief Executive Officer of CAMP4 Therapeutics.

Mr. Mandel-Brehm was previously an entrepreneur partner with Polaris Partners and held key business development and operations leadership roles at leading biotech companies. Most recently he served as part of the Business Development group at Biogen, where he led multiple strategic activities and corresponding transactions. Prior to Biogen, Mr. Mandel-Brehm held several roles of increasing responsibility at Genzyme as part of the business development group for the company’s rare disease business unit.

Mr. Mandel-Brehm earned a BA in Biology from Washington University in St. Louis and holds an MBA from the University of Michigan.